Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3267-3272

  Akashi, Akira ^a   Ono, Saori ^a   Kuwano, Koichi ^a   Arai, Sumio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DEOXYCHOLIC ACID; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GALACTOSAMINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MACROPHAGE; MOLECULAR WEIGHT; MONOCYTE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THERMOSTABILITY;

EID: 0030036871     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3267-3272.1996     Document Type: Article

References (38)

1. Arai, S., M. Furukawa, T. Munakata, K. Kuwano, H. Inoue, and T. Miyazaki. 1990. Enhancement of cytotoxicity of active macrophages by mycoplasma: role of mycoplasma-associated induction of tumor necrosis factor-α (TNF-α) in macrophages. Microbiol. Immunol. 34:231-243.
2. Ausubel, F., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strahl. 1987. Current protocols in molecular biology, suppl. 14, p. 9.2.5. John Wiley & Sons, Inc., New York.
3. Belsheim, M. R., R. Z. Darwish, W. C. Watson, and B. Schieven. 1983. Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology 85:364-369.
4. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
5. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fisher. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4620.
6. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
7. Bone, R. C. 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
8. Burchett, S. K., W. M. Weaver, J. A. Westall, A. Larsen, S. Kronheim, and C. B. Wilson. 1988. Regulation of tumor necrosis factor/cacheclin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 140:3473-3481.
9. Carro, T., N. C. Pedersen, P. L. Beaman, and R. Muss. 1989. Subcutaneous abscesses and arthritis caused by a probably bacterial L-form in cats. J. Am. Vet. Med. Assoc. 11:1583-1588.
10. Collart, M. A., D. Belin, J. Vassalli, S. de Kossodo, and P. Vassalli. 1986. γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:2113-2118.
11. Fischer, H., M. Dohlsten, U. Andersson, G. Hedlund, P. Ericsson, J. Hansson, and H. O. Sjogren. 1990. Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T cells. J. Immunol. 144:4663-4669.
12. Fong, V., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, and A. Cerami. 1989. Antibodies to cacheclin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
13. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110-2115.
14. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76:5939-5943.
15. Glauser, M. P., U. Heumann, J. D. Baumgartner, and J. Cohen. 1994. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin. Infect. Dis. 18(Suppl. 2):S205-S216.
16. Gorman, C., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
17. Hayes, M. P., and K. C. Zoon. 1993. Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor. Infect. Immun. 61:3222-3227.
18. Herbelin, A., E. Ruuth, D. Delorme, C. Michel-Herbelin, and F. Prax. 1994. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect. Immun. 62:4690-4694.
19. Heumann, D., C. Barras, A. Severin, M. P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
20. Jacobson, M. A., H. Gellermann, and H. Chambers. 1988. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am. J. Med. 85:172-176.
21. Kagan, G. Y., E. I. Koptelova, and B. M. Pokrovsky. 1965. Isolation of pleuropneumonia-like organisms, L-form and heteromorphous growth of bacteria from the cerebrospinal fluid of patients with septic meningitis. J. Hyg. Epidemiol. Microbiol. Immunol. 9:310-317.
22. Keller, R., W. Fisher, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60:3664-3672.
23. Krumholz, H. M., M. A. Sande, and B. Lo. 1989. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am. J. Med. 86:776-779.
24. Kuwano, K., A. Akashi, I. Matsu-Ura, M. Nishimoto, and S. Arai. 1993. Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus. Infect. Immun. 61:1700-1706.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
26. Levine, S. J., D. A. White, and A. O. S. Fels. 1990. The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with human immunodeficiency virus. Am. Rev. Respir. Dis. 141:89-93.
27. Mathison, J. C., E. Wolfson, and R. J. Ulevitch. 1988. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1925-1937.
28. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
29. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336-2340.
30. Parsonnet, J., and Z. A. Gillis. 1988. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1. J. Infect. Dis. 158:1026-1033.
31. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261.
32. Raviglione, M. C., R. Battan, A. P.-Mendez, P. A. Casillas, M. P. Mullen, and A. Taranta. 1989. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am. J. Med. 86:780-786.
33. Roulston, A., R. Lin, P. Beauparlant, M. A. Wainberg, and J. Hiscott. 1995. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in mycloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:481-505.
34. See, R. H., W. W. S. Kum, A. H. Chang, S. H. Goh, and A. W. Chow. 1992. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect. Immun. 60:2612-2618.
35. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171:35-47.
36. Timmerman, C. P., E. Mattsson, L. Martinez-Martinez, L. De Graaf, J. A. G. Van Strijp, H. A. Verbrugh, J. Verhoef, and A. Fleer. 1993. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect. Immun. 61:4167-4172.
37. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Monogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (London) 330:662-664.
38. Wessel, D., and U. I. Flugge. 1984. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:141-143.